References
- Ferreri AJ. How I treat primary CNS lymphoma. Blood. 2011;118(3):510–522.
- Miller DC, Hochberg FH, Harris NL, et al. Pathology with clinical correlations of primary central nervous system non-Hodgkin’s lymphoma. The Massachusetts General Hospital experience 1958-1989. Cancer. 1994;74(4):1383–1397.
- Yap KK, Sutherland T, Liew E, et al. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay. J Med Imag Radiation Oncol. 2012;56(2):179–186.
- Küker W, Nägele T, Korfel A, et al. Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neurooncol. 2005;72(2):169–177.
- Ahn SJ, Shin HJ, Chang JH, et al. Differentiation between primary cerebral lymphoma and glioblastoma using the apparent diffusion coefficient: comparison of three different ROI methods. PLos One. 2014;9(11):e112948.
- Shiels MS, Pfeiffer RM, Besson C, et al. Trends in primary central nervous system lymphoma incidence and survival in the U.S. Br J Haematol. 2016;174(3):417–424.
- Mendez JS, Ostrom QT, Gittleman H, et al. The elderly left behind - changes in survival trends of primary central nervous system lymphoma over the past four decades. Neuro Oncol. 2017;(9):20.
- Eloranta S, Brånvall E, Celsing F, et al. Increasing incidence of Primary CNS lymphoma but no improvement in survival in Sweden 2000-2013. Eur J Haematol. 2018;100(1):61–68.
- Haldorsen IS, Krossnes BRK, Aarseth JH, et al. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003: time trends in a 15-year national survey. Cancer. 2007;110(8):1803–1814.
- Meulen MVD, Dinmohamed AG, Visser O, et al. Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989–2015. Leukemia. 2017;31(8):1822–1825.
- Mappa S, Marturano E, Licata G, et al. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy. Hematol Oncol. 2013;31(3):143–150.
- Tracy B, Loeffler JS. Primary CNS lymphoma. JCO. 2006;24(8):1281–1288.
- Hiemcke-Jiwa LS, Leguit RJ, Snijders TJ, et al. Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: review of literature and future opportunities. Crit Rev Oncol/Hematol. 2018;127:56–65.
- Bakshi R, Mazziotta JC, Mischel PS, et al. Lymphomatosis cerebri presenting as a rapidly progressive dementia: clinical, neuroimaging and pathologic findings. Dement Geriatr Cogn Disord. 1999;10(2):152–157.
- Hatanpaa KJ, Fuda F, Koduru P, et al. Lymphomatosis cerebri: A diagnostic challenge. JAMA Neurol. 2015;72(9):1066.
- Kitai R, Hashimoto N, Yamate K, et al. Lymphomatosis cerebri: clinical characteristics, neuroimaging, and pathological findings. Brain Tumor Pathol. 2012;29(1):47–53.
- Izquierdo C, Velasco R, Vidal N, et al. Lymphomatosis cerebri: a rare form of primary central nervous system lymphoma. Analysis of 7 cases and systematic review of the literature. Neuro Oncol. 2016;18(5):707–715.
- Barrantes-Freer A, Engel AS, Winkler A, et al. Diagnostic red flags: steroid‐treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelination. Brain Pathology. 2018;28(2):225–233.
- Wang G, Liu Y, He F. Primary lymphoma involving cranial nerves and cauda equina detected by (18)F-FDG PET/CT and MRI. Nuklearmedizin Nuclear Med. 2016;55(5):N46–N8.
- Lars F, Kristoph J, Peter M, et al. The diagnostic value of cerebrospinal fluid pleocytosis and protein in the detection of lymphomatous meningitis in primary central nervous system lymphomas. Haematologica. 2006;91(3):429–430.
- Bromberg JEC, Breems DA, Kraan J, et al. CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies. Neurology. 2007;68(20):1674–1679.
- Canovi S, Campioli D. Accuracy of flow cytometry and cytomorphology for the diagnosis of meningeal involvement in lymphoid neoplasms: A systematic review. Diagn Cytopathol. 2016;44(10):841–856.
- Chapuy B, Roemer MG, Stewart C, et al. Targetable genetic features of primary testicular and primary central nervous system lymphomas. Blood. 2016;127(7):869–881.